ATN Pro Members Get the Playbook.
Member Q&A: Cutting acquisition costs with Jonathan Geller. Nov. 17.
The product would effectively function as an “electronic version of GLP-1” obesity drugs, founding partner Nyx He said
A recent survey found that patient satisfaction with GLP-1 treatment dropped significantly once off the medications, with a high likelihood of regaining weight. Experts point to maintaining treatment and exercising as key preventive factors
As GLP-1 use rises, gyms are reshaping strength programming, adding clinical services and building referral partnerships to meet a fast-changing member base.
New research shows GLP-1 users are shelling out roughly $449 a month on fitness amid broader lifestyle shifts, although the general consensus is conflicted on whether weight-loss drugs are a net benefit for the fitness and wellness industry
The focus of the partnership has shifted to whether solutions targeting the microbiome can deliver benefits alongside GLP-1-based medicines
Nestle believes the drugs are also creating a new market for products designed to address the side effects of rapid weight loss
Speaking with top certification organizations and personal training tech providers, ATN surveys how personal training is evolving at the midpoint of 2026
The peptide market keeps growing amid mounting tensions between longevity practitioners and scientists. For some, reward — financial or medical — might outweigh risk
Gyms are evolving to keep up with climbing GLP-1 adoption, offering muscle-preservation workouts, telehealth partnerships and integrated wellness services
The retired NFL legend appeared on Fox Business to tout his partnership with GLP-1-prescribing telehealth platform eMed, Brady's latest move into the wellness space
Sign Up to Our Newsletter
